Previous 10 | Next 10 |
Midatech Pharma (MTP) +50% on the successful encapsulation of a biologic using Q-Sphera technology.Cellect Biotechnology (APOP) +40%.Clearside Biomedical (CLSD) +23% after filing registration statement for Quoin Pharma merger.Nano-X Imaging (NNOX) +16% after submits 510(k) appl...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investors! We’re starting off the day with a look at the biggest pre-market stock movers. Source: f11photo/Shutterstock.com We’re seeing lots of movement from medical stocks today as trad...
Tel Aviv, Israel, June 16, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), a developer of innovative technology that enables the functional selection of stem cells, announced today that it has filed a registration statement, including a joint proxy statement/prospectus...
Vertex Energy (VTNR) +28%.Cloudera CLDR +24% on being acquired by Clayton, Dubilier & Rice and KKR for $5.3 billion.Orbsat Corp Common Stock (OSAT) +19%.AMC Entertainment Holdings AMC +16% on raising $230.0 million.Lineage Cell Therapeutics LCTX +14% on updat...
3 Penny Stocks to Watch Moving Big In Early Morning Trading Moving further into May, there are plenty of penny stocks to watch. But, as smart investors, we need to be picky about which penny stocks go into our portfolios. And right now, that pickiness means that investors should hav...
Are These Penny Stocks The Best Ones For Your May Watchlist? As we inch closer toward the second half of May, penny stocks are highly in focus. Some of the most sought-after assets in the stock market right now are biotech penny stocks as well as tech stocks and blockchain pen...
Cellect Biotechnology (APOP) announces positive data from the company's open label Phase 1/2 clinical trial of its ApoGraft technology in Israel for bone marrow transplantations in cancer treatment.The primary objective, safety and tolerability of ApoGraft administered to patients with h...
Tel Aviv, Israel, April 19, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), a developer of innovative technology that enables the functional selection of stem cells, today announced positive data from the Company's open label Phase 1/2 clinical trial of its ApoGraft...
TEL AVIV, Israel, March 29, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: “APOP”), a developer of innovative technology that enables the functional selection of stem cells, today reported financial and operating results for the fourth quarter and full year ended...
HighPoint Resources (HPR) -17%.Vuzix (VUZI) -16% on pricing $85M stock offering.Cellect Biotechnology (APOP) -12%GAN (GAN) -10% on Q4 earnings release.Hall of Fame Resort & Entertainment (HOFV) -9%.Cinedigm (CIDM) -8%.Co-Diagnostics (CODX) -8% on FY earnings ...
News, Short Squeeze, Breakout and More Instantly...
Cellect Biotechnology Ltd. Company Name:
APOP Stock Symbol:
NASDAQ Market:
Tel Aviv , Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: “APOP”) (the “Company”), announced today the record date and distribution date for the contingent value rights (the “CVRs”) to be distributed in connection with the...
Cellect Biotechnology Ltd (NASDAQ: APOP) shareholders approved the previously announced strategic merger agreement with Quoin Pharmaceuticals, the company said in a press release on Monday. Shares of the Israel-headquartered firm jumped about 50% this morning. The stock has now ...